Skip to main content
OpenTrials

Clinical trial condition

Dermatitis

Explore clinical trials studying Dermatitis. Study availability and eligibility vary by location and protocol.

176 public trials 19 recruiting studies
Refine in advanced search Browse all conditions

Dermatitis trial results

Completed

Study on Hypoallergenic Hair Dye

NCT04772482

Conditions
Allergy; Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Contact Dermatitis, +11 more
Locations
  • University of Minnesota Minneapolis, Minnesota, United States
View Trial Details
Completed

A Study of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroids in Japanese Participants With Moderate-to-Severe Atopic Dermatitis

NCT04760314

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +9 more
Locations
  • Yanagihara dermatology clinic Ainokawa, Ichikawa-shi, Chiba, Japan
  • Kawashima Dermatology Clinic Ichikawa-shi, Chiba, Japan
  • Charme Clinique Matsudo, Chiba, Japan
  • Yasumoto Dermatology Clinic Chikushino-shi, Fukuoka, Japan
View all 37 locations
View Trial Details
Completed

Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis

NCT04178967

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • Investigate MD Scottsdale, Arizona, United States
  • Northwest Arkansas Clinical Trials Center Rogers, Arkansas, United States
  • Bakersfield Dermatology and Skin Cancer Medical Group Bakersfield, California, United States
  • Center For Dermatology Clinical Research, Inc. Fremont, California, United States
View all 89 locations
View Trial Details
Completed

Study to Assess the Safety and Efficacy of Lebrikizumab (LY3650150) in Adolescent Participants With Moderate-to-Severe Atopic Dermatitis

NCT04250350

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • Pinnacle Research Group Anniston, Alabama, United States
  • Arkansas Research Trials, LLC North Little Rock, Arkansas, United States
  • Hope Clinical Research Canoga Park, California, United States
  • First OC Dermatology Fountain Valley, California, United States
View all 70 locations
View Trial Details
Completed

Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis (ADvocate1)

NCT04146363

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • Johnson Dermatology Fort Smith, Arkansas, United States
  • Wallace Medical Group, Inc. Beverly Hills, California, United States
  • California Dermatology & Clinical Research Institute Encinitas, California, United States
  • Belle Aimee Skincare Clinic Fountain Valley, California, United States
View all 94 locations
View Trial Details

Related conditions